Innate and Adaptive Immune Markers in Farming Lifestyle and Early Atopic Diseases
Innate and Adaptive Immune Markers in Farming Lifestyle and Early Atopic Diseases
批准号:
10633369
负责人:
Kirsi Jarvinen-Seppo
金额:
$43.89万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-07 至 2028-03-31
关键词:
ATAC-seqAllergensAllergicAllergic DiseaseAnti-Allergic AgentsAsthmaAtopic DermatitisBifidobacteriumBiological MarkersBirthBloodCellsClinical DataCommunitiesConstitutionConstitutionalDevelopmentDiseaseDisease OutcomeEnrollmentEpigenetic ProcessEpithelial CellsEpitheliumExtrinsic asthmaFamilyFarmFecesFlow CytometryFoodFood HypersensitivityFrequenciesGene ExpressionGenerationsGenetic TranscriptionGoalsHomingIgEImmuneImmunityImmunologic MarkersImmunophenotypingIn VitroIndividualInfantInflammatoryInterventionIntestinal permeabilityKLRB1 geneLife StyleLipopolysaccharidesMaintenanceMeasuresMediatingMemoryMennoniteModificationMyeloid CellsOutcomePathogenicityPermeabilityPhenotypePopulationPrevention strategyProliferatingRegulatory T-LymphocyteReproducibilityRiskRoleSamplingSchool-Age PopulationSignal TransductionSiteSkinSterilityStimulusT cell differentiationT-LymphocyteTLR4 geneTestingTrainingUmbilical Cord BloodViralWaterWorkatopyclinical developmentcohortcytokineearly detection biomarkersepigenomeexperiencefood antigenfunctional outcomesgastrointestinalgastrointestinal epitheliumgut microbiomehigh riskin vivoinfancyinfant gut microbiomeintestinal barrierintestinal epitheliummicrobialmonocytenovelreceptorresponsesingle-cell RNA sequencingtranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Atopic constitution starts shortly after birth with atopic dermatitis (AD) and sensitization to foods, which is an
important marker for the potential development of clinical food allergy (FA). A farming lifestyle has been
reproducibly associated with a reduced risk of asthma and atopic disease at school-age. Sustained microbial
exposure experienced when living on farms is proposed to confer protection through priming of innate immune
populations/receptors, whereas increased monocyte activation and hyper-responsive cytokine response to
lipopolysaccharide (LPS) stimulation was associated with increased risk of allergic asthma. Epigenetic
modifications in myeloid cells can lead to a change in functional potential to a second stimulus, either an
enhanced or suppressed response. This long-lived modification in immune potential, a concept known as trained
immunity, can lead to an array of functional outcomes, similar to the T cell differentiation outcomes that they
influence. Farmlife protection is also proposed to be mediated through expansion of regulatory T (Treg) cells.
Through epigenetic mechanisms or direct interaction with immune cells, microbial metabolites promote
generation of Tregs. This can reinforce tolerance through maintenance of epithelial barrier integrity, which is
known to be compromised in skin in AD, facilitating epicutaneous allergen sensitization and in gastrointestinal
sites in FA. Despite several large birth cohorts, the early mechanisms and biomarkers of AD and FA are poorly
characterized, although the emerging strategies for prevention call for a need to identify those at risk.
Our preliminary studies in the “Zooming in to Old Order Mennonites” (ZOOM)1 birth cohort identified novel
memory effector Th2 subpopulations in infancy as a marker of development of allergic sensitization in infants
born to Rochester urban families (ROC). In comparison, our studies found a higher frequency of gut-homing
(β7+) Tregs and Tregs that express TIGIT, an inhibitory co-stimulatory molecule, in infants from Old Order
Mennonites (OOM), a traditional agrarian community protected against atopic diseases. In addition, ROC infants
demonstrated a hyper-inflammatory monocyte response in cord blood. Utilizing samples and clinical data
collected under the already enrolled ZOOM1 cohort (n=160) and to be enrolled expansion cohort ZOOM 2
(n=120), we will be testing our central hypothesis that infants who will develop atopic diseases generate Th2-
skewed T cell populations in early infancy, whereas the protected infants develop gut-homing suppressive Tregs,
and monocytes hyporesponsive to LPS and viral targets. We have three specific aims: Aim 1 will assess
infant adaptive and innate immune markers in farming and urban lifestyles associated with protection
and atopic disease outcomes. Aim 2 will evaluate the role of T and innate cell transcriptome and
epigenome on atopic disease outcomes. Aim 3 will measure the association between gut barrier
function, farming lifestyle, and atopic diseases. Upon completion of this work, we expect to identify
mechanisms and biomarkers associated with anti-allergic immunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administration Core
-
批准号:10633365
-
项目类别:
-
资助金额:$4.62万
-
财政年份:2023
-
负责人:Kirsi Jarvinen-Seppo
-
依托单位:
Expecting Mothers' Study of Consumption or Avoidance of Peanut and Egg (ESCAPE)
-
批准号:10733927
-
项目类别:
-
资助金额:$76.45万
-
财政年份:2023
-
负责人:Kirsi Jarvinen-Seppo
-
依托单位:
Biomarkers of Atopy Beginning Early (BABE)
-
批准号:10633364
-
项目类别:
-
资助金额:$145.75万
-
财政年份:2023
-
负责人:Kirsi Jarvinen-Seppo
-
依托单位:
Role of B. infantis in Development of Atopic Diseases
-
批准号:10286718
-
项目类别:
-
资助金额:$27.07万
-
财政年份:2021
-
负责人:Kirsi Jarvinen-Seppo
-
依托单位:
Role of B. infantis in Development of Atopic Diseases
-
批准号:10432099
-
项目类别:
-
资助金额:$20.58万
-
财政年份:2021
-
负责人:Kirsi Jarvinen-Seppo
-
依托单位:
Development of Mucosal and Systemic Immunity and Risk of Food Allergy
-
批准号:10158965
-
项目类别:
-
资助金额:$28.29万
-
财政年份:2020
-
负责人:Kirsi Jarvinen-Seppo
-
依托单位:
Impact of Breast Milk on Infant Gut Microbiome
-
批准号:9756486
-
项目类别:
-
资助金额:$25.03万
-
财政年份:2018
-
负责人:Kirsi Jarvinen-Seppo
-
依托单位:
Development of Mucosal and Systemic Immunity and Risk of Food Allergy
-
批准号:10265645
-
项目类别:
-
资助金额:$24.52万
-
财政年份:2017
-
负责人:Kirsi Jarvinen-Seppo
-
依托单位:
Impact of Maternal Diet and Supplements on Breast Milk Composition
-
批准号:9912500
-
项目类别:
-
资助金额:$16.81万
-
财政年份:2017
-
负责人:Kirsi Jarvinen-Seppo
-
依托单位:
Development of Mucosal and Systemic Immunity and Risk of Food Allergy
-
批准号:9895622
-
项目类别:
-
资助金额:$44.94万
-
财政年份:2017
-
负责人:Kirsi Jarvinen-Seppo
-
依托单位:
Human Milk Cytokines and Oligosaccharides in Development of Allergic Diseases
-
批准号:9181044
-
项目类别:
-
资助金额:$8.76万
-
财政年份:2016
-
负责人:Kirsi Jarvinen-Seppo
-
依托单位:
Role of breast milk in development of neonatal oral tolerance to foods
-
批准号:8713905
-
项目类别:
-
资助金额:$12.95万
-
财政年份:2011
-
负责人:Kirsi Jarvinen-Seppo
-
依托单位:
Role of breast milk in development of neonatal oral tolerance to foods
-
批准号:8408839
-
项目类别:
-
资助金额:$12.95万
-
财政年份:2011
-
负责人:Kirsi Jarvinen-Seppo
-
依托单位:
Role of breast milk in development of neonatal oral tolerance to foods
-
批准号:8528461
-
项目类别:
-
资助金额:$12.95万
-
财政年份:2011
-
负责人:Kirsi Jarvinen-Seppo
-
依托单位:
Role of breast milk in development of neonatal oral tolerance to foods
-
批准号:8337694
-
项目类别:
-
资助金额:$12.95万
-
财政年份:2011
-
负责人:Kirsi Jarvinen-Seppo
-
依托单位:
海外基金